Vetsys Pharmaceutical
Vetsys Pharmaceutical
Advanced pharmaceutical and herbal formulations meeting international safety standards.
Pioneering purity in the global supply chain through technological mastery.
The global industrial landscape for Non-GMO Ingredients has undergone a seismic shift. As consumers worldwide demand transparency, the "Clean Label" movement has transitioned from a niche preference to a mandatory industrial standard. From North America to Europe, multinational corporations are actively restructuring their procurement strategies to prioritize verified Non-GMO origins, particularly in the sectors of pharmaceuticals, veterinary health, and cosmeceuticals.
In this context, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, stands as a beacon of reliability. With a registered capital of 30 million RMB, we have integrated the principles of Non-GMO purity into every facet of our production. Our facility includes specialized workshops for powders, premixes, injections, and herbal drug extracts, all operating under strict Good Manufacturing Practices (GMP). This infrastructure ensures that every ingredient we produce—whether for animal health or human topical applications—is free from genetic modification and contaminants.
The development trend of the Non-GMO industry is now leaning towards AI-assisted extraction and molecular precision. Vetsys distinguishes itself through technological innovation, maintaining an independent research institute with world-class scientists. By focusing on traditional Chinese medicine herbal extracts—such as Lily Bulb, Burdock Root, and Graviola—we provide global partners with ingredients that are not only natural but are processed using modern pharmaceutical rigor, ensuring high bioavailability and safety.
Our commitment to quality management and sustainable global expansion.
Compliance with strict Good Manufacturing Practices ensures that all products meet the highest international safety and quality standards.
Equipped with five specialized laboratories, our team of scientists adapts quickly to market demands for cutting-edge Non-GMO solutions.
Investing in green technologies to minimize environmental impact while promoting the well-being of both animals and humans.
Our workshops produce everything from granules and tablets to oral solutions, providing a one-stop-shop for complex procurement needs.
Actively expanding into international markets with high-quality, innovative health solutions and research collaborations.
Quality is our cornerstone. Rigorous checks are integrated into every production phase to maintain long-term partner trust.
Meeting the evolving needs of global B2B buyers and manufacturers.
Global procurement teams in the 21st century are no longer just looking for "suppliers"; they are looking for strategic manufacturing partners. The demand for Non-GMO ingredients is particularly high in Western Europe and North America, where regulatory frameworks like the Non-GMO Project and EU labeling laws dictate market entry. As a China-based factory, Vetsys offers the unique advantage of scale-driven cost efficiency combined with pharmaceutical-grade quality control.
Our ingredients find localized applications in diverse scenarios:
By 2015, Vetsys achieved annual domestic sales of over USD 20 million, a testament to our market dominance and the reliability of our supply chain. Today, our vision is to bring these high-standard, sustainable animal and human health solutions to every corner of the globe.
Transparency in our vertical production capabilities.
Exploring our wider range of pharmaceutical and healthcare solutions.
